We are live on !
Find out more
Robert Olstein Olstein Capital Management
AUM
$458M
Turnover
5.83%
1-Year Est. Return
6.27%
Robert Olstein is the founder of Olstein Capital Management and a long-time advocate of forensic accounting and quality-of-earnings analysis in equity investing. His process looks beyond headline multiples to assess earnings sustainability and balance-sheet risk. Olstein’s work is frequently referenced by investors who prioritize accounting diligence.
This Fund
S&P 500
This Quarter Est. Return
-16.42%
1 Year Est. Return
+6.27%
3 Year Est. Return
+16.62%
5 Year Est. Return
+3.39%
10 Year Est. Return
+96.48%
AUM
$667M
AUM Growth
-$131M
(-16%)
Cap. Flow
-$48.7K
Cap. Flow % of AUM
Cap. Flow %
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
19.24%
Holding
108
New
2
Increased
47
Reduced
46
Closed
4
Avg Time Held
4.6
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$13.9M |
| 2 |
WestRock Company
WRK
|
+$10.8M |
| 3 |
Zimmer Biomet
ZBH
|
+$10.1M |
| 4 |
ScottsMiracle-Gro
SMG
|
+$5.83M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$3.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$16M |
| 2 |
JetBlue
JBLU
|
+$12.1M |
| 3 |
Timken Company
TKR
|
+$5.44M |
| 4 |
Dollar Tree
DLTR
|
+$3.84M |
| 5 |
Winnebago Industries
WGO
|
+$3.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.62% |
| 2 | Industrials | 17.25% |
| 3 | Healthcare | 15.77% |
| 4 | Technology | 15.4% |
| 5 | Financials | 14.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
DELISTED
WestRock Company
WRK
| $21.9M | 3.28% |
501,000
+230,000
| +85% | +$10.8M |
2016 Q1
25 quarters
|
|
|
2
Zimmer Biomet
ZBH
$18.7B
| $21.7M | 3.25% |
185,000
+85,000
| +85% | +$10.1M |
2013 Q2
36 quarters
|
|
|
3
Alphabet (Google) Class C
GOOG
$3.91T
| $11.8M | 1.77% |
108,000
+33,000
| +44% | +$3.9M |
2017 Q1
21 quarters
|
|
4
Invesco
IVZ
$12.5B
| $10.9M | 1.64% |
677,200
-82,800
| -11% | -$1.57M |
2014 Q1
33 quarters
|
|
5
Johnson & Johnson
JNJ
$634B
| $10.8M | 1.62% |
61,000
-10,000
| -14% | -$1.78M |
2020 Q2
8 quarters
|
|
6
Cisco
CSCO
$417B
| $10.5M | 1.57% |
246,000
+27,000
| +12% | +$1.29M |
2013 Q2
36 quarters
|
|
7
Sensata Technologies
ST
$5.81B
| $10.3M | 1.55% |
250,000
+51,500
| +26% | +$2.37M |
2017 Q2
20 quarters
|
|
8
WESCO International
WCC
$15.6B
| $10.3M | 1.55% |
96,400
-13,400
| -12% | -$1.65M |
2014 Q2
32 quarters
|
|
|
9
DELISTED
Warner Bros
WBD
| $10.1M | 1.51% |
+749,000
| New | +$13.9M |
2022 Q2
0 quarters
|
|
10
Dine Brands
DIN
$394M
| $10M | 1.5% |
154,000
-17,250
| -10% | -$1.23M |
2017 Q1
21 quarters
|
|
11
Jones Lang LaSalle
JLL
$13.9B
| $9.8M | 1.47% |
56,000
+4,000
| +8% | +$797K |
2021 Q1
5 quarters
|
|
12
Generac Holdings
GNRC
$10.8B
| $9.8M | 1.46% |
46,410
-90
| -0.2% | -$22.1K |
2018 Q2
16 quarters
|
|
13
FedEx
FDX
$70.1B
| $9.7M | 1.46% |
43,000
-10,500
| -20% | -$2.24M |
2016 Q1
25 quarters
|
|
14
Mohawk Industries
MHK
$8.28B
| $9.6M | 1.44% |
77,206
-21,794
| -22% | -$2.89M |
2018 Q3
15 quarters
|
|
15
United Parcel Service
UPS
$84.4B
| $9.49M | 1.42% |
52,000
+11,000
| +27% | +$2.01M |
2015 Q2
28 quarters
|
|
16
Becton Dickinson
BDX
$53.8B
| $9.37M | 1.4% |
38,000
-8,125
| -18% | -$2.06M |
2013 Q2
36 quarters
|
|
17
SS&C Technologies
SSNC
$19.7B
| $9.29M | 1.39% |
160,000
+47,000
| +42% | +$3.02M |
2020 Q3
7 quarters
|
|
18
Corning
GLW
$108B
| $9.26M | 1.39% |
294,000
+27,000
| +10% | +$930K |
2013 Q4
34 quarters
|
|
19
Reynolds Consumer Products
REYN
$4.88B
| $9.26M | 1.39% |
339,550
+11,500
| +4% | +$322K |
2021 Q2
4 quarters
|
|
20
Baxter International
BAX
$13.1B
| $8.99M | 1.35% |
140,000
+13,000
| +10% | +$943K |
2017 Q2
20 quarters
|
|
21
Quest Diagnostics
DGX
$26.8B
| $8.96M | 1.34% |
67,400
-7,600
| -10% | -$1.04M |
2020 Q4
6 quarters
|
|
22
Fidelity National Information Services
FIS
$19.2B
| $8.59M | 1.29% |
93,700
| – | – |
2022 Q1
1 quarter
|
|
23
Corteva
CTVA
$8.28B
| $8.5M | 1.27% |
157,000
-30,600
| -16% | -$1.78M |
2019 Q3
11 quarters
|
|
24
Kulicke & Soffa
KLIC
$3.88B
| $8.48M | 1.27% |
198,000
+7,100
| +4% | +$352K |
2017 Q4
18 quarters
|
|
25
DELISTED
Walgreens Boots Alliance
WBA
| $8.45M | 1.27% |
223,000
+8,000
| +4% | +$344K |
2017 Q3
19 quarters
|
|
Similar funds
PCP
VI
Robert Olstein's Q2 2022 Portfolio in Review
As of Q2 2022, Robert Olstein held 108 positions worth $667M, down 16% from $798M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Robert Olstein's Q2 2022 filing shows 2 new, 47 increased, 46 reduced and 4 closed positions. Its largest new stake was Warner Bros: 749,000 shares worth $10.1M. The largest sale was Discovery, Inc. Series C Common Stock, an estimated $16M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.
- Robert Olstein's largest Q2 2022 buy was Warner Bros: 749,000 shares worth $10.1M.
- Robert Olstein added most to WestRock Company in Q2 2022, an estimated $10.8M increase.
- Robert Olstein's biggest Q2 2022 reduction was Timken Company, cutting an estimated $5.44M.
- Robert Olstein fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $16M.
- Robert Olstein's ten largest holdings make up 19% of its $667M portfolio in Q2 2022.
- Robert Olstein opened 2 new positions and closed 4 in Q2 2022.
- Robert Olstein's portfolio value fell 16% quarter-over-quarter to $667M.
Based on Olstein Capital Management's 13F filing for Q2 2022, filed 25 Jul 2022.